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Functional neuroimaging uses activity-dependent
changes in cerebral blood flow to map brain activity,
but the contributions of presynaptic and postsynap-
tic activity are incompletely understood, as are the
underlying cellular pathways. Using intravital multi-
photon microscopy, wemeasured presynaptic activ-
ity, postsynaptic neuronal and astrocytic calcium
responses, and erythrocyte velocity and flux in olfac-
tory glomeruli during odor stimulation in mice. Odor-
evoked functional hyperemia in glomerular capillar-
ies was highly correlated with glutamate release,
but did not require local postsynaptic activity. Odor
stimulation induced calcium transients in astrocyte
endfeet and an associated dilation of upstream arte-
rioles. Calcium elevations in astrocytes and func-
tional hyperemia depended on astrocytic metabo-
tropic glutamate receptor 5 and cyclooxygenase
activation. Astrocytic glutamate transporters also
contributed to functional hyperemia through mecha-
nisms independent of calcium rises and cyclooxyge-
nase activation. These local pathways initiated by
glutamate account for a large part of the coupling
between synaptic activity and functional hyperemia
in the olfactory bulb.
INTRODUCTION
Synaptic activity induces a localized increase in cerebral blood
flow (CBF) (Iadecola and Nedergaard, 2007). These hemody-
namic changes are used to map brain function using functional
neuroimaging (Raichle and Mintun, 2006). The steps from neural
activity to CBF changes remain incompletely determined. Also
unclear is how CBF changes should be used to make inferences
regarding electrophysiological and metabolic changes in neural
networks. In this regard, functional hyperemia has been variously
correlated with neuronal input and local synaptic processing
(Logothetis and Wandell, 2004; Lauritzen, 2005), spiking activity
of principal output neurons (Rees et al., 2000), or a combinationof the two (Mukamel et al., 2005). Part of the uncertainty arises
from the difficulty in disentangling presynaptic and postsynaptic
contributions using traditional measures such as local field po-
tentials. Therefore, there is a paucity of studies that individually
probe the presynaptic, postsynaptic, and extrasynaptic compo-
nents of excitatory transmission under physiological conditions,
and determine their contributions to functional hyperemia follow-
ing physiological stimulation.
The cellular signaling pathways that underlie functional hyper-
emia are also incompletely understood. Astrocytes can dilate
(Zonta et al., 2003a; Filosa et al., 2004) and constrict arterioles
(Mulligan and MacVicar, 2004) in vitro. Vasodilation was mainly
mediated by metabotropic glutamate receptors (mGluRs) and
prostaglandins (Zonta et al., 2003a). In vivo, calcium uncaging
in astrocytes triggers arteriolar dilation via a cyclooxygenase 1
(COX1)-dependent mechanism (Takano et al., 2006). A fraction
of the CBF response remained unresponsive to mGluR or COX
inhibition in these studies, indicating that astrocytes might also
employ additional pathways. It has also remained unclear
whether these or other mechanisms contribute to functional
hyperemia following physiological stimulation in vivo.
Here, we have investigated the contributions of presynaptic,
postsynaptic, and extrasynaptic activity to functional hyperemia,
as well as the signaling pathways that underlie them, in a well-
defined system using physiological stimulation. We used multi-
photon microscopy to image local neuronal and astrocytic activ-
ity and CBF changes in olfactory bulb glomeruli. Glomeruli are
ideally suited for this purpose, because they represent anatom-
ical and functional units onto which all olfactory sensory axons
that express the same odor receptor converge (Mombaerts
et al., 1996). It has also been shown that odor-evoked functional
hyperemia respects glomerular boundaries (Kida et al., 2002;
Chaigneau et al., 2003).
To monitor glutamate release in glomeruli, we used mice that
express the presynaptic probe synaptopHluorin (spH) (Miesen-
bo¨ck et al., 1998) in olfactory sensory neurons (Bozza et al.,
2004). Odor stimulation results in graded fluorescence increases
in activated glomeruli of these mice (Bozza et al., 2004; Wacho-
wiak et al., 2005). We recorded spH, postsynaptic and astrocytic
calcium responses, and CBF parameters in glomeruli. We found
that functional hyperemia is correlatedwithpresynaptic glutamate
release, but not with local postsynaptic activity. Through a series
of imaging, electrophysiological, and immunohistochemicalNeuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc. 897
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Astrocytic Control of Olfactory Blood FlowFigure 1. spH Fluorescence Correlates with Presynaptic Electric Activity
(A) Glomeruli (green) were visualized by exciting presynaptic spH with blue light through a cranial window over the olfactory bulbs (OB). Electrical activity was
recorded with an electrode. MOE, main olfactory epithelium.
(B) Graded presynaptic fluorescence and electrical activity following odor stimulation. OB were imaged with a CCD camera. The highlighted glomerulus (arrow-
head) responded to methyl tiglate at the indicated concentrations with a graded fluorescence increase (green traces). Presynaptic electrical activity recorded
from this glomerulus showed a similar increase in spike rate. The duration of odor presentation is indicated by the gray area.
(C) The spike rate increase recorded from activated glomeruli shows a monotonic linear correlation with spH fluorescence. The line represents the Deming linear
regression.
(D) Separation of presynaptic spiking activity and glutamate release by GABAB receptor modulation. Microinjection of the GABAB agonist baclofen strongly
reduced odor-evoked OMP-spH increase, while the olfactory receptor neuron spiking rate increase remained unchanged (mean ± SEM, *p < 0.05, paired
t test).experiments, we provide evidence that different astrocytic path-
ways mediate these CBF changes.
RESULTS
spH Fluorescence Correlates with Presynaptic
Electrical Activity
Odor-evoked changes in spH fluorescence are linked to presyn-
aptic activity (Bozza et al., 2004; Wachowiak et al., 2005), but the
exact relation of spH signal to electrical activity in vivo has not
been quantified. Therefore, we recorded multiunit activity of ol-
factory sensory neurons and spH fluorescence from glomeruli
in mice that express spH under control of the olfactory marker
protein (OMP) promoter (Bozza et al., 2004). We recorded fluo-
rescence with a CCD camera through a cranial window (Figures
1A and 1B). Mice were stimulated with different concentrations898 Neuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc.of methyl tiglate (0.1%–6.4%). To avoid habituation, we pre-
sented five different odors between each concentration step.
Each stimulus was preceded by pure air. We identified activated
glomeruli by their fractional fluorescence change compared with
air (0.61% ± 0.09% DF/F; n = 18 glomeruli from five mice). Elec-
trodes were then placed into responsive glomeruli (Figure 1B).
We observed a linear monotonic relation between spH fluores-
cence and the integrated olfactory nerve spike rate (Figure 1C;
r = 0.90, p < 0.001, Pearson correlation), indicating that spH fluo-
rescence can be used as a marker of presynaptic activity over
a wide dynamic range of physiological stimuli.
To demonstrate that spH fluorescence indicates transmitter
release and not spike activity, we applied baclofen to the record-
ing region by local microinjection (10 mM, n = 2 mice). Baclofen
decreases glomerular glutamate release by activating presynap-
tic g-aminobutyrate-B (GABAB) receptors (Wachowiak et al.,
Neuron
Astrocytic Control of Olfactory Blood FlowFigure 2. Simultaneous Multiphoton Imaging of Presynaptic Activity and CBF In Vivo
(A and B) Glomeruli were visualized by their spH expression and appeared at a depth of100–150 mm. Blood vessels were simultaneously imaged by labeling the
plasmawith Texas red dextran. Vessels in the glomerular layer were capillaries (defined as diameter <5 mm). Larger vessels are visible in upper layers at the border
of the field of view because of the natural curvature of the bulb.
(C and D) Higher magnification (insets in [A] and [B]) revealed structural details of glomeruli, as well as erythrocytes as dark objects within the labeled plasma
(arrowheads). The arrow indicates the length and orientation of the line scan.
(E) High-frequency line scans of spH fluorescence (green) and plasma fluorescence (red) recorded from the glomerulus depicted in (C) and (D). Erythrocytes
appear as bands in the labeled plasma (red). Extension of the line scan allowed the simultaneous recording of presynaptic activity (green). The arrow indicates
the direction of the scan. White rectangles indicate regions of interest in (F) and (G).
(F) Space-time matrix of erythrocyte ghosts demonstrates that velocity (inversely proportional to the slope of the dark bands), flux (proportional to the number of
bands), and spH increase during odor presentation.
(G) Traces of the individual parameters measured in the glomerulus depicted in (C) and (D) during the presentation of valeric acid (gray area). spH fluorescence
increased promptly, before the increase of velocity and flux. Linear density was calculated as the ratio of flux and velocity. Changes are relative to baseline levels,
measured during air presentation preceding the stimulus.2005). spH fluorescence was strongly reduced, while presynap-
tic spike rate remained unchanged (Figure 1D), consistent with
the origins of the recordedmultiunit activity in the olfactory nerve
layer, and that of spH signal in presynaptic terminals.
Simultaneous Multiphoton Imaging of CBF and
Presynaptic Activity Following Physiological Stimulation
We used multiphoton microscopy to monitor spH fluorescence
and CBF simultaneously in glomeruli in vivo (Figure 2A). We visu-
alized blood vessels by tail vein injections of Texas red dextran
(Figure 2B). Texas red and spH could be excited at the same
wavelength with minimal bleedthrough in emission (see Movie
S1, available online). Vessels in the glomerular layer were capil-
laries (Figure 2B) as previously reported (Chaigneau et al., 2003),
while surface arteries and arterioles were located in the olfactory
nerve layer (Figure 2B and see below). Higher magnifications of
the glomerular layer (Figure 2C) revealed erythrocytes as dark
objects moving in the fluorescently labeled plasma (Figure 2D,
Movie S1). Their velocity and flux were determined by line scans
along the central axis of glomerular capillaries (Dirnagl et al.,
1992; Kleinfeld et al., 1998). By extending the line scans beyond
the capillary length and into the glomerular tissue, we recorded
changes in spH fluorescence and CBF simultaneously at high
temporal and spatial resolution (Figure 2E). Upon odor stimula-
tion, velocity and flux increased (Figures 2F and 2G).Local Glomerular CBF Is Correlated with Presynaptic
Glutamate Release
We used 25 different odorants (see Table S1, available online) to
investigate the relation between spH intensity and functional hy-
peremia. Odors and recording regions were selected to achieve
a sparse glomerular activation pattern (1 activated glomeruli
per field of view) to avoid possible overlap of neighboring co-
activated glomeruli and to study responses of single glomeruli.
Stimulation led to an increase in spH fluorescence (5.8% ±
0.4%; n = 103 glomeruli from 21 mice), with a large range from
0.3% to 16.9%. Baseline CBF parameters were obtained during
the 10 s presentation of fresh air (velocity, 0.65 ± 0.11mm/s; flux,
64.1 ± 9.8 s1; n = 152 capillaries from 21 mice). An increase of
velocity and flux was observed in 94% of activated glomeruli.
The onset of functional hyperemia, measured as the rise of flux
to half-maximal amplitude, occurred later than the onset of the
simultaneously recorded spH signal (difference of 2.2 ± 0.3 s,
p < 0.05, paired t test).
Following stimulation, velocity increased by 25.4% ± 3.6%
and flux by 34.5% ± 4.1% (Movie S2). The changes in velocity
and flux showed a wide dynamic range (velocity 5.4% to
71.3%, flux 8.4% to 76.9%) and were correlated with the ampli-
tude of spH increase (Figure 3A). In addition, spH and CBF
changes exhibited similar habituation when the same stimulus
was intentionally presented in short temporal progression
(Figure 3B). The correlation between spH fluorescence andNeuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc. 899
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Astrocytic Control of Olfactory Blood FlowFigure 3. Presynaptic Glutamate Release and CBF Are Highly Correlated
(A) A glomerulus responded to two different odors with different amplitudes of spH fluorescence, as expected from different binding affinities of a given odorant
receptor to different odors. The amplitude of CBF increase, shown as velocity changes during odor presentations, was related to presynaptic activity. The gray
area indicates the duration of odor presentation.
(B) Measuring spH fluorescence in a glomerulus during repeated presentation of the same odor in short intervals revealed habituation of the presynaptic
response, indicated by the smaller response to the second stimulus. A similar habituation pattern was observed in the velocity changes.
(C and D) Velocity and flux changes were highly correlated with presynaptic activity. Lines represent the Deming linear regression.CBF changes was significant (velocity, r = 0.90; flux, r = 0.81, p <
0.001, Pearson correlation), and the data were well fitted by a
linear regression (Figures 3C and 3D).
Local Postsynaptic BlockadeDoesNot Affect Functional
Hyperemia in Glomeruli
Since local CBF changes were correlated with presynaptic activ-
ity (and therefore, release of glutamate), we investigated the in-
volvement of postsynaptic N-methyl-D-aspartate (NMDA) and
a-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) re-
ceptors, which contribute to functional hyperemia in the neocor-
tex and cerebellum (Lauritzen, 2005). To locally block these re-
ceptors, we injected antagonists into glomeruli. Injection
pipettes were coloadedwith Texas red to confirm localized injec-
tions into glomeruli of interest (Figure S1, available online).
To confirm blockade of ionotropic glutamate receptors, we
recorded calcium changes in juxtaglomerular cells and mitral/
tufted (M/T) cell dendrites following odor stimulation. Cells
were labeled with the calcium indicator X-Rhod-1 acetoxymethyl900 Neuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc.ester (AM) by multicell bolus loading (Figure 4A) (Stosiek et al.,
2003). In responding glomeruli, we detected calcium transients
in juxtaglomerular cells in all cases (Figures 4A and 4B; DF/F
23% ± 6%, n = 81 cells from five mice). Calcium levels increased
0.9 ± 0.2 s after the onset of the spH increase. Local injection of
theNMDA receptor blocker APV (50mM) and the AMPA receptor
inhibitor 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX; 5 mM)
abolished responses in 94% of cells (Figures 4A and 4B). A frac-
tion of these cells likely represent astrocytes, which are sensitive
to mGluR blockade (see below). Moreover, the spH increase fol-
lowing odor stimulation was significantly larger after NMDA/
AMPA blockade, consistent with presynaptic disinhibition (Fig-
ures 4A–4C) (McGann et al., 2005). This presynaptic augmenta-
tion was abolished when baclofen (100 mM) was coinjected with
APV/CNQX (Figure 4C).
Although activity of periglomerular cells was abolished by in-
jection of APV/CNQX, it remained possible that the dendrites
of the principal M/T cells retained some responsiveness. We
therefore labeled dendrites of M/T cells with X-Rhod-1 AM using
Neuron
Astrocytic Control of Olfactory Blood Flowa modified loading protocol (see Experimental Procedures). Op-
tical sections starting from the glomerular region going toward
the mitral cell body layer were used to identify apical dendrites
ofM/T cells (Figure 4D).We thenmeasured odor-evoked calcium
responses in apical dendrites (Figure 4D; peak DF/F 18% ± 3%;
n = 4mice). These responseswere fully blocked by local injection
of APV and CNQX (Figure 4D), again confirming blockade of
postsynaptic activity by this treatment.
Although postsynaptic activity was blocked by local injection
of APV/CNQX, odor-evoked hyperemia was not reduced
(Figure 4C). In fact, it was slightly but significantly stronger, con-
sistent with more glutamate released presynaptically and, ac-
cordingly, a stronger CBF response (Figure 4C; n = 3 mice).
When baclofen (100 mM) was injected together with APV/
CNQX, the fractional spH increase and functional hyperemia
were not different compared with those of control (Figure 4C;
n = 2 mice).
Astrocytes Bridge Glomerular Synapses
with Blood Vessels
Since release, but not local ionotropic activity of glutamate, was
correlated with functional hyperemia, we next investigated the
extrasynaptic contributions of glutamate. Because astrocytes
detect glutamate released at glomerular synapses (De Saint
Jan and Westbrook, 2005), we speculated that they act as an in-
termediary between glutamate and CBF changes. Staining for
glial fibrillary acidic protein (GFAP) in fixed olfactory bulb slices
demonstrated that each astrocyte sends its processes into a sin-
gle glomerulus (Figures 5A and 5B). Double immunostaining for
GFAP and the vascularmarker laminin B2/g1 revealed that within
glomeruli, astrocytic processes reach into the glomerular core
and contact capillaries (Figures 5C and 5D). Astrocytes con-
tacted glomerular capillaries as well as larger upstream vessels
feeding into glomeruli (Figure 5D, inset). Lower-magnification im-
ages revealed that the complete vascular tree—i.e., large sur-
face vessels, medium-sized vessels penetrating the olfactory
nerve layer, and glomerular capillaries—is covered by astrocytes
(Figures 5E and 5F). Furthermore, staining for aquaporin-4,
a marker for astrocytic endfeet (Simard et al., 2003), revealed
a dense astrocytic network around blood vessels and through-
out spH-negative portions of glomeruli (Figures 5G and 5H).
Astrocytes throughout the Vascular Network Show
Odor-Selective Calcium Elevations
To probe astrocytic activity in vivo, we labeled the olfactory bulb
of mice expressing GFP under the GFAP promotor with X-Rhod-
1 AMbymulticell bolus loading. Olfactory astrocytes are strongly
labeled with GFP in these mice (De Saint Jan and Westbrook,
2005).
Astrocytes exhibited calcium responses to odor stimulation
(Figure 6A) that commenced shortly after stimulus onset (0.9 ±
0.3 s). Glomerular astrocytes responded specifically to only
one or very few odors (Figure 6A), indicating that they are stimu-
lated by glutamate released in activated glomeruli.
To test whether periarteriolar astrocytes in the olfactory nerve
layer also respond to odors, we labeled astrocytes by topical ap-
plication of X-Rhod-1 AM (Hirase et al., 2004). Blood vessels
were visualized by tail vein injections of fluorescein isothyocya-nate (FITC) dextran. Arterioles were distinguished from venules
by their thicker walls and by their direction of flow away from sur-
face vessels. Similar to glomerular astrocytes, astrocytic endfeet
located around upstream arterioles of the same vascular net-
work also responded to odor stimulation (Figure 6B; DF/F
4.3% ± 0.4%). These calcium elevations appeared shortly after
stimulus onset (1.0 ± 0.2 s). Because astrocytic endfeet moved
rhythmically with heartbeat- and breathing-related movements,
we could obtain successful recordings only in a subset of astro-
cytes (n = 11 endfeet from six mice).
Odor-Evoked Calcium Responses in Astrocytic Endfeet
Are Associated with Arteriolar Dilation
The main mechanism regulating CBF in capillaries is a change in
the diameter of upstream arterioles. We hypothesized that astro-
cytic endfeet around penetrating arterioles would receive odor-
evoked signals from glomerular astrocytes and convey these
signals onto arterioles. To test this possibility, we measured
changes in arteriolar cross-sectional area by labeling the vascu-
lature with FITC dextran. We found that odor stimulation resulted
in a significant increase in the cross-sectional area of penetrating
arterioles between 13.4% and 35.1% (mean: 21.9% ± 4.2%),
corresponding to a flow increase between 29% and 81% (as-
suming Poiseuille’s law). Baseline fluctuations in cross-sectional
area without stimulation were significantly lower (3.4% ± 1.1%).
We then combined calcium imaging of astrocytes in GFAP-
GFP mice with arteriolar cross-sectional area recordings. We
found that odor-evoked calciumelevations in periarteriolar astro-
cytic endfeet were accompanied by increases in arteriolar cross-
sectional area (Figure 6B). The two signals were strongly corre-
lated both temporally and spatially: invariably, calciumelevations
in astrocytic endfeet preceded or coincided with arteriolar dila-
tion, and nonreacting arterioles showed no calcium changes in
surrounding endfeet. Small baseline fluctuations of arteriolar
area were not associated with astrocytic calcium changes.
Glutamate Mediates Functional Hyperemia
via Astrocytic mGluR5
We then sought to determine the intracellular pathways respon-
sible for the vascular changes. These experiments were carried
out in glomerular capillaries rather than in arterioles to simulta-
neously monitor spH responses and ensure that they were not
altered in nonspecific ways. Arterioles are above glomeruli and
therefore spH cannot be recorded in those optical sections.
We tested whether mGluRs are involved in functional hyper-
emia following sensory stimulation. Topical application of the
group I/II mGluR antagonist (S)-a-methyl-4-carboxyphenylgly-
cine (MCPG, 50 mM) significantly reduced the odor-evoked in-
crease in velocity by 48% ± 3% and flux by 52% ± 4% (n = 13
glomeruli from four mice; p < 0.05, paired t test). Since topically
applied drugs may not adequately penetrate brain tissue, we
also microinjected MCPG into the bulb, which also reduced ve-
locity and flux responses at two different concentrations (1 mM
and 50 mM; Figure 7A). Importantly, spH fluorescence remained
unchanged (Figure 7A).
Several mGluR subtypes are also expressed by M/T cells (En-
nis et al., 2006), and astrocytes respond to currents generated by
mGluRs located on these cells (De Saint Jan and Westbrook,Neuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc. 901
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Astrocytic Control of Olfactory Blood FlowFigure 4. Local Postsynaptic Activity Is Not Required for Functional Hyperemia
(A) Calcium imaging revealed block of postsynaptic responses in juxtaglomerular cells. Cells were labeled with the calcium indicator X-Rhod-1 AM (red) by mul-
ticell bolus loading. Presynaptic spH fluorescence (green trace) and postsynaptic calcium (red traces) increased following odor stimulation. After local injection of
the NMDA receptor inhibitor APV and the AMPA receptor blocker CNQX, postsynaptic calcium changes were completely abolished (blue traces associated with
right panel), while the presynaptic signal was augmented (blue trace in left panel), consistent with presynaptic disinhibition. Arrows indicate the start of stimulus.
(B) Analysis of presynaptic spH and postsynaptic calcium signals in juxtaglomerular cells before and after NMDA and AMPA receptor blockade (APV/CNQX)
shows that calcium elevations are fully blocked, while the spH increase is augmented (mean ± SEM, **p < 0.001, *p < 0.05, paired t test).902 Neuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc.
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6-methyl-2-(phenylethynyl)-pyridine (MPEP), a selective antago-
nist of mGluR5, which in the glomerular layer is exclusively ex-
pressed by astrocytes (van den Pol, 1995). MPEP (100 mM)
injected into the bulb led to a significant reduction (40%) of
functional hyperemia (Figure 7B). Again, spH fluorescence was
not altered (Figure 7B, paired t test).
To ascertain that sufficient concentrations of mGluR blockers
had been applied, we recorded calcium signals from glomerular
astrocytes in GFAP-GFP mice (Figure 7C). MCPG (1 mM) and
MPEP (100 mM) both suppressed odor-evoked calcium re-
sponses in astrocytes (Figure 7C). MCPG reduced responses
in most juxtaglomerular cells, while MPEP was specific for astro-
cytes (Figure 7C).
Astrocytic Glutamate Uptake Represents an Additional
Pathway of Functional Hyperemia
Because a significant fraction of the CBF response remained un-
responsive to mGluR inhibition, we explored the involvement of
additional astrocytic signaling pathways. Another major pathway
for glutamatergic actions on astrocytes involves uptake through
amino acid transporters (Marcaggi and Attwell, 2004). Glutamate
uptake has been implicated in the initiation of astrocytic glucose
utilization (Voutsinos-Porche et al., 2003), and in the generation
of intrinsic optical signals in the olfactory bulb (Gurden et al.,
2006).
To investigate whether glutamate uptake into astrocytes rep-
resents an additional neurovascular signaling pathway, we first
applied the broad-spectrum glutamate transporter inhibitor
DL-threo-b-Benzyloxyaspartic acid (TBOA) topically to the olfac-
tory bulb (10 mM; n = 5 mice). This treatment reduced odor-
evoked velocity increase by 40% ± 3% and flux increase by
35% ± 3% (n = 18 glomeruli from six mice; p < 0.05, paired t
test). A similar effect was observed when TBOA was injected
into the glomerular region (100 mM, velocity 39% ±
3%, flux 35% ± 5% reduction from control; n = 8 glomeruli
from three mice; Figure 7D). spH responses remained similar
to those of control (Figure 7D).
TBOA inhibits both astrocytic and neuronal glutamate trans-
porters, both of which are expressed in glomeruli (Utsumi
et al., 2001). To achieve higher selectivity for astrocytic gluta-
mate uptake, we applied dihydrokainate (DHK) (400 mM) by local
microinjection. DHK selectively inhibits the astrocytic glutamate
transporter GLT-1, which is also expressed in glomeruli (Utsumi
et al., 2001). DHK reduced the odor-evoked CBF response while
the spH increase remained unchanged (Figure 7D; n = 15 glo-
meruli from five mice; p < 0.05, paired t test). A similar reduction
was also observed at a higher concentration (1 mM; velocity,
32% ± 4%; flux, 26% ± 4%; n = 3 mice).Inhibition of glutamate uptake into astrocytes increases the
extracellular concentration and half-life of glutamate, which
could alter its action on glutamate receptors. We indeed ob-
served this effect in initial experiments, which showed stronger
postsynaptic responses after local TBOA injection (data not
shown). To control for potentially higher ionotropic and metabo-
tropic receptor activity after glutamate transport blockade, we
blocked glutamate receptors by combined local injection of
APV (50 mM), CNQX (5 mM), andMCPG (50mM), and presynap-
tic GABAB receptors with baclofen (100 mM). This treatment re-
duced odor-evoked CBF responses (Figure 7E). However, func-
tional hyperemia decreased even further after subsequent
injection of DHK (1 mM; Figure 7E; n = 7 glomeruli from three
mice) or TBOA (1 mM; Figure 7E; n = 6 glomeruli from three
mice), indicating that glutamate uptake contributes to functional
hyperemia independently of ionotropic and metabotropic gluta-
mate receptors, as well as presynaptic GABAB receptors. The
effects of TBOA and MPEP were found for all odors without
apparent spatial or odor-specific differences.
Functional Hyperemia Mediated by mGluRs,
but Not by Glutamate Uptake, Depends on COX
As noted above, the calcium increase in glomerular astrocytes
was dependent on mGluR5 (Figure 7C). However, in agreement
with other reports (Bernardinelli et al., 2004), we observed no sig-
nificant changes of the astrocytic calcium response when TBOA
or DHK was injected locally into glomeruli of GFAP-GFP mice
(TBOA, 19.3% ± 3.2% versus 22.5% ± 3.4% DF/F %; DHK,
17.1% ± 4.2% versus 19.1% ± 3.7% DF/F %; paired t test; n =
26 astrocytes from four mice). There was a slight tendency for
the calcium responses to increase, but this effect did not reach
statistical significance.
Direct activation of astrocytes induces vasodilation by COX1
activation and prostaglandin synthesis (Zonta et al., 2003a; Ta-
kano et al., 2006). We asked whether the pathways mediated
by mGluR and glutamate uptake are also COX1 dependent. Im-
munohistochemistry of bulb slices from GFAP-GFP mice re-
vealed that COX1 is strongly and exclusively expressed by astro-
cytes in the glomerular layer (Figure 8A), indicating that COX1
inhibitors can be used to selectively target glomerular astro-
cytes. In contrast, COX2 expression was sparse and mostly
observed in neurons below the glomerular layer (Figure S2).
The COX1 inhibitor SC-560, applied by local microinjection
(500 mM), reduced odor-evoked velocity and flux increase by
34% ± 6% and 36% ± 7%, respectively (Figure 8B; n = 12 glo-
meruli from four mice). No significant further reduction was
seen after subsequent local injection of the mGluR5 antagonist
MPEP (Figure 8B), indicating that COX1 activation occurs
downstream of mGluR5 activation. Moreover, the exclusive(C) Local postsynaptic activity does not contribute to functional hyperemia. Presynaptic activity was augmented after postsynaptic blockade with APV/CNQX.
This presynaptic disinhibitionwas abolished by local GABAB receptor blockadewith baclofen (100 mM). Velocity and flux increased to higher levels comparedwith
control after local NMDA/AMPA blockade, and were not different from control after combined local NMDA/AMPA/GABAB blockade (mean ± SEM, *p < 0.05,
Student’s t test).
(D) Odor-evoked calcium responses in apical M/T cell dendrites are blocked by NMDA/AMPA receptor inhibition. M/T cells in OMP-spH mice were loaded with
X-Rhod-1 AM (red). Their apical dendrites were followed up (arrowheads) to the glomerular layer (spH, green). The position of each optical section is indicated in
mm below pial surface. Note that spH signals are only visible above 135 mm. Odor stimulation (gray area) evoked calcium transients in M/T cell dendrites.
Calcium responses were blocked by APV/CNQX, while the spH signal was augmented. Yellow boxes indicate regions of interest.Neuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc. 903
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part of a common astrocytic signaling pathway. In contrast, in
mice treated with SC-560 in a separate group (n = 10 glomeruli
Figure 5. Astrocytes Couple Synapses with the Vasculature
(A and B) Immunohistochemistry of olfactory bulb slices from OMP-spH mice
showed that astrocytes (visualized with an antibody against GFAP, red) are
located around and within glomeruli. Glomerular astrocytes are generally
associated with a single glomerulus.
(C and D) Astrocytes (GFAP, red) send their processes into the glomerular core
(arrowheads) and contact blood vessels (visualized with an antibody against
laminin B2/g1, blue) with multiple finer processes. The inset in (D) shows an as-
trocyte contacting a vessel feeding into the glomerulus from the overlying
nerve layer.
(E and F) Astrocytes (GFAP, red) contact blood vessels (laminin B2/g1, blue)
throughout the vascular tree. Astrocytic processes (arrowheads) abundantly
engulf large surface vessels, penetrating vessels in the olfactory nerve layer,
and glomerular capillaries.
(G and H) Immunohistochemistry of astrocytic endfeet with an antibody
against aquaporin-4 (AQP4, red) revealed the full coverage by astrocytes of ol-
factory bulb vessels (arrowhead) and spH-free zones within glomeruli (arrow).904 Neuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc.from four mice), local injection of TBOA reduced functional hy-
peremia even further (Figure 8B). Similarly, application of TBOA
resulted in an additional reduction of functional hyperemia
when applied after MPEP in the same animal (MPEP: velocity
42% ± 3%, flux 41% ± 6%; TBOA: velocity 59% ± 5%, flux
61%± 3%, reduction of hyperemia relative to control; n = 18 glo-
meruli from three mice; p < 0.05, repeated-measures ANOVA
followed by Tukey Test).
Cerebrovascular Reactivity Following Local
Drug Application
Finally, we ascertained that the observed changes of the CBF
response were due to the specific modulation of functional hy-
peremia induced by neural activity. Baseline CBF values are re-
ported in Table 1. Drugs were coinjected with FITC (Figure S3).
To test vascular reactivity, we bolus-injected the carbonic anhy-
drase inhibitor acetazolamide (14 mg/kg i.v.), which induces
vasodilation independently of neural activity by increasing tissue
pCO2. Acetazolamide induced an increase in velocity and flux in
glomerular capillaries (Figure S3). No differences were observed
after injections of MPEP, DHK, TBOA, and APV/CNQX, but SC-
560 reduced pCO2 reactivity (n = 2 mice for each; Figure S3) as
previously reported (Niwa et al., 2001). However, this reduced
pCO2 reactivity is unlikely to be a confounding factor, because
SC-560 interacted differently with TBOA and MPEP in terms of
its effect on functional hyperemia.
DISCUSSION
The aim of this study was to investigate the contribution of the
individual components of excitatory synaptic transmission to
functional hyperemia, as well as the underlying pathways, in
the olfactory bulb using physiological stimuli. We find that pre-
synaptic activity in glomeruli is highly correlated with functional
hyperemia, and that arteriolar tone and local capillary perfusion
are regulated by astrocytes. Two mechanisms contributed to
this effect: (1) mGluR5 and COX activation and (2) astrocytic glu-
tamate uptake through GLT-1. These results suggest that astro-
cytes, by sensing released glutamate, regulate local CBF adap-
tation to neuronal activity. Furthermore, depending on the
stimulus paradigm and system investigated, different mecha-
nisms may prevail in the precise control of CBF.
Presynaptic and Postsynaptic Contributions
to Functional Hyperemia
Because of the localized and prompt increase in CBF following
neuronal activation, functional hyperemia is the most important
marker to map regional brain activity and observe the brain
‘‘at work’’ in humans and animals (Raichle and Mintun, 2006).
Despite this fundamental importance for basic and clinical neu-
roscience, it remains unclear which aspects of neural activity
are relevant for functional hyperemia. One view holds that the
output of principal neurons, measured as the efferent spiking ac-
tivity, correlates with functional hyperemia (Rees et al., 2000).
Other studies have demonstrated that the input to neurons and
local synaptic processing (as measured by the local field poten-
tial) are better correlated with functional hyperemia (Logothetis
and Wandell, 2004; Lauritzen, 2005). Yet another study
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predict CBF changes equally well (Mukamel et al., 2005).
The uncertainty regarding local synaptic processing may stem
in part from the fact that the local field potential, i.e., the sumof all
local synaptic events in a given area (Logothetis and Wandell,
2004), does not always differentiate local presynaptic from post-
synaptic activity. In glomeruli, the local field potential is gener-
ated by postsynaptic currents (Aroniadou-Anderjaska et al.,
1997), and therefore is not a direct indicator of presynaptic activ-
ity. Moreover, postsynaptic blockers can also influence transmit-
ter release. For example, the present study and others (McGann
et al., 2005) found that local postsynaptic blockade increased
glutamate release by presynaptic disinhibition in the olfactory
bulb. In other conditions, AMPA blockade can actually decrease
glutamate release (Brickley et al., 2001), and systemic applica-
tion of AMPA blockers not only blocks postsynaptic cortical re-
ceptors, but also glutamate release fromafferent thalamocortical
projections (Gsell et al., 2006). Furthermore, topical application
of postsynaptic blockers will not only decrease activity of princi-
pal output neurons, but also decrease presynaptic glutamate re-
lease from local excitatory neurons in that network, which are
normally recruited by recurrent activity. It is therefore possible
that the effect on functional hyperemia attributed to postsynaptic
activity was in part related to presynaptic or extrasynaptic activ-
ity, neither of which was measured concomitantly. We have
overcome this uncertainty by the use of gene-targeted mice in
which presynaptic activity can be accurately measured, enabling
Figure 6. Astrocytic Calcium Responses in Glomeruli
Are Conveyed Upstream and Are Associated with
Arteriolar Dilation
(A) Calcium imaging (X-Rhod-1 AM, red) in GFAP-GFP mice
(green) revealed that glomerular astrocytes show odor-spe-
cific calcium responses. In this example, an astrocyte, identi-
fied by GFP expression (arrowheads), showed a strong re-
sponse to ethyl tiglate, but not to acetal or octanoic acid
(gray area, odor stimulation).
(B) Odor-evoked responses in astrocytic endfeet are associ-
ated with dilation of penetrating arterioles. Blood vessels
were identified by tail vein injection of FITC dextran (green) in
GFAP-GFP mice. GFP expression in astrocytes (arrow) and
perivascular endfeet (arrowhead) appears dim because GFP
is less fluorescent than FITC. Calcium imaging of astrocytic
endfeet (arrowhead) using X-Rhod-1 AM (red) revealed that
odor stimulation evoked calcium elevations similar to those
in glomerular astrocytes. Perivascular astrocytic calcium re-
sponses were associated with arteriolar dilation, measured
as change in cross-sectional area. In this example, cross-sec-
tional area changed from 104.7 mm2 to 123.9 mm2, i.e., by
18.3%, corresponding to a flow increase of 40%. Images
correspond to time points indicated by arrows in the graph.
us to introduce predictable perturbations down-
stream of neural activity—this has not always
been the case in previous studies, which often
monitored some mixture of presynaptic and post-
synaptic activity. In addition, we have measured
activation of many key steps, starting from trans-
mitter release all the way to CBF, under natural sen-
sory stimulation.
Using an optical marker of presynaptic vesicle exocytosis, we
show that there is an exquisite analog coupling between neural
activity and CBF, despite many steps between the two variables.
Our data suggest that functional hyperemia in the olfactory bulb,
and by inference functional neuroimaging signals, is represen-
tative of local synaptic processing, and specifically incoming
neuronal activity, rather than spiking activity.
Functional hyperemia remained unchanged when local post-
synaptic activity of juxtaglomerular and M/T cells was blocked.
In contrast, ionotropic glutamate receptor blockade attenuated
functional hyperemia in the cerebellum and neocortex (Yang
and Iadecola, 1996; Offenhauser et al., 2005; Gsell et al.,
2006).While themechanisms outlined abovemay in part contrib-
ute to the differences, it is also possible that different pathways
exist in the olfactory bulb, or that the prevailing mechanism con-
trolling functional hyperemia is stimulus dependent. In this re-
gard, it is important to emphasize that we focused on local
CBF responses in single glomeruli by using a very sparse activa-
tion paradigm. In another study, it was reported that clustered
activation of more glomeruli, i.e., a stronger stimulus paradigm,
resulted in CBF responses that were attenuated by global, but
not local, postsynaptic blockade (Chaigneau et al., 2007). The
long-range networks capable of controlling CBF between coac-
tivated glomeruli are unknown, but may involve interglomerular
excitatory or inhibitory connections. Interestingly, a quantitative
analysis of glomerular metabolic demands (Nawroth et al., 2007)
reported that the postsynaptic receptor response contributes toNeuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc. 905
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comparable to our conditions, but increases exponentially to
one-third with activation patterns comparable to those used by
Chaigneau et al. (2007). It is intriguing to speculate that presyn-
aptic and extrasynaptic actions of glutamate prevail at sparse
glomerular activations, while the contribution of postsynaptic
mechanisms to functional hyperemia increases with stronger
activation. It will be important in future research to investigate
Figure 7. Astrocytes Mediate Functional Hyperemia through mGluR5 and Glutamate Uptake
(A and B) Functional hyperemia is mediated in part by astrocytic mGluR5. The broad-spectrummGluR inhibitor MCPG reduced functional hyperemia at different
concentrations (A). The mGluR5 inhibitor MPEP attenuated functional hyperemia to a similar extent (B). Both drugs were applied by local microinjection into the
glomerular layer. CBF parameters are relative to baseline. spH responses remained unchanged (mean ± SEM, **p < 0.001, *p < 0.05, paired t test).
(C) Local mGluR inhibition blocks odor-evoked astrocytic calcium responses. Juxtaglomerular cells (and presynaptic fibers) in GFAP-GFPmice were labeled with
X-Rhod-1 AM (red). Astrocytes were identified by their expression of GFP (green, arrows). MCPG and MPEP both blocked calcium responses in astrocytes.
MCPG reduced calcium in different cell types, whereas the effect of MPEP was specific for astrocytes, consistent with exclusive expression of mGluR5 in as-
trocytes in the glomerular layer (mean ± SEM, **p < 0.001, paired t test). Areas 1 and 2 represent calcium signals from an astrocyte (identified by GFP expression)
and a GFP-negative cell, respectively. Gray areas represent the duration of odor stimulation.
(D) Astrocytic glutamate uptake also contributes to functional hyperemia. Changes of spH and velocity/flux before and after application of the broad-spectrum
glutamate transporter inhibitor TBOA, along with dihydrokainate (DHK), a specific blocker of the astrocytic glutamate transporter GLT-1, are shown (mean ± SEM,
**p < 0.001, *p < 0.05, paired t test).
(E) Glutamate transport contributes to functional hyperemia independently of glutamatergic and GABAB receptors. Local inhibition of NMDA, AMPA, metabo-
tropic glutamate, and GABAB receptors reduced functional hyperemia. An additional reduction was observed after blockade of glutamate transporters with
TBOA, or after inhibition of astrocytic GLT-1 with DHK (mean ± SEM, *p < 0.05, repeated-measures ANOVA followed by Tukey Test).906 Neuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc.
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hyperemia mainly by postsynaptic mechanisms, and localized
or weak stimuli, by contrast, predominantly rely on presynaptic
and extrasynaptic mechanisms.
Different Astrocytic Mechanisms Control Local
Glomerular CBF Responses
A distinctive feature of the olfactory system is that activity-de-
pendent CBF (Kida et al., 2002; Chaigneau et al., 2003) and met-
abolic signals (Lancet et al., 1982) follow glomerular boundaries.
Moreover, glomeruli contain only capillaries, which depend on
diameter changes of upstream arterioles. These upstream ves-
sels must dilate to allow for hyperemia in an activated glomeru-
lus. Given the distinctly stratified anatomy of the olfactory bulb, it
is unlikely that postsynaptic ionotropic currents, which occur be-
low the nerve layer, can mediate the necessary local upstream
adaptations alone. We propose that astrocytes, which respond
to glutamate in glomeruli, mediate these changes, for the follow-
ing reasons. First, we show that astrocytes contact synapses
and capillaries in glomeruli, as well as penetrating arterioles in
the nerve layer. Second, we find that glomerular astrocytes re-
spond to physiological stimulation in an odor-specific fashion.
Third, we show that astrocytes form a functional syncytium—
glomerular astrocytes activated by an odor convey these signals
onto astrocytes located around upstream penetrating arterioles.
Finally, we find that these odor-evoked calcium signals in periar-
teriolar astrocytic endfeet are associated with changes in arteri-
Figure 8. Functional Hyperemia Mediated by mGluR
and Glutamate Uptake Is Controlled by Separate
Pathways
(A) COX1 is exclusively expressed by astrocytes in the glomer-
ular layer. GFAP-GFP mice were used to identify astrocytes
(green). Glomeruli were identified as cell-poor areas sur-
rounded by juxtaglomerular cells (Hoechst 33258, blue).
COX1 (red) was only detected in astrocytes (merged images,
right).
(B) Functional hyperemia mediated bymGluR5, but not by glu-
tamate uptake, depends on COX1 activation. SC-560 reduced
the odor-evoked CBF response. Application of MPEP after
SC-560 had no additional effect, indicating that mGluR5 af-
fects CBF predominantly through COX activation. In contrast,
TBOA reduced functional hyperemia even further after SC-560
application (mean ± SEM, *p < 0.05, repeated-measures
ANOVA followed by Tukey Test).
olar diameter. Therefore, by their distinctive associ-
ation with single glomeruli, astrocytes convey the
input from nerve fibers expressing a single odor re-
ceptor onto capillaries and upstream vessels, thus
contributing to adequate local perfusion.
Earlier studies have shown that astrocytes re-
spond to sensory stimulation (Wang et al., 2006)
and change arteriolar tone when directly activated
(Takano et al., 2006). Here we show that in the ol-
factory bulb, astrocytic calcium elevations evoked
by physiological sensory stimulation also control
functional hyperemia. Although we did not manipu-
late single astrocytes, we likely achieved adequate
selectivity for astrocytes for the following reasons. First, drug
targets such as mGluR5, COX1, and GLT-1 are exclusively
expressed by glomerular astrocytes. Second, we showed that
the effect of GLT-1 inhibition on functional hyperemia still existed
after blockade of glutamate and GABAB receptors. Third, all ex-
periments were carried out by local drug injections, to minimize
systemic effects and achieve adequate drug levels.
We found that astrocytes contribute to functional hyperemia
by at least two pathways: mGluR5 and COX1 activation, and
a second pathway that includes glutamate uptake. The pathway
mediated by mGluR5 and COX1 is also involved in vasodilation
mediated by direct astrocytic stimulation in vitro (Zonta et al.,
2003a) and in vivo (Takano et al., 2006), and possibly involves
COX activation by mGluR5-induced calcium transients (Zonta
et al., 2003b). However, other studies found that COX2 rather
than COX1 contributes to functional hyperemia (Niwa et al.,
2000, 2001). Interestingly, SC-560 reduces resting CBF in the
neocortex (Niwa et al., 2001), but had no significant effect on
basal velocity and flux in glomeruli in our study. Moreover, olfac-
tory bulb COX2 expression differed strongly from that of the neo-
cortex (Figure S2). Thus, the role of COX isoforms in cerebrovas-
cular regulation may differ between the olfactory bulb and other
regions. We note, however, that the selectivity of SC-560 for
COX1 is lower in vivo (Brenneis et al., 2006), and we cannot
completely exclude a role for COX2 in our experiments.
Uptake of glutamate into astrocytes constituted an additional
pathway of functional hyperemia, accounting for about one-thirdNeuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc. 907
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Baseline parameters were obtained during presentation of pure air preceding a stimulus. Velocity and flux were compared before (Ctl.) and after
application of drugs (paired t test).of the CBF response. A recent study showed that glutamate up-
take also contributed to activity-dependent changes in intrinsic
optical signals (Gurden et al., 2006), but it was not reported
whether neuronal or glial uptakewasassociatedwith intrinsic sig-
nals. However, in the olfactory bulb, the response spectrumof in-
trinsic optical signals across different wavelengths is different
from the absorption spectra of oxyhemoglobin and deoxyhemo-
globin (Meister and Bonhoeffer, 2001), indicating that cell swell-
ing, and not CBF changes, is the predominant source of intrinsic
signals in the olfactory bulb. Furthermore, mGluR activation,
which accounted for a large fraction of functional hyperemia in
our study, has no effect on intrinsic signals (Gurden et al., 2006).
The intracellular pathways by which astrocytic glutamate up-
take mediates functional hyperemia remain to be elucidated.
Although glutamate transport appeared independent of larger
calcium changes in astrocytic somata, we cannot exclude the
possibility that glutamateuptake inducessmall local calcium tran-
sientsnotdetectedby in vivo imaging.Moreover,glutamate trans-
port consumes energy (Attwell and Laughlin, 2001) and may initi-
ate astrocytic glycolysis and lactate release (Voutsinos-Porche
et al., 2003). Astrocytes have been hypothesized to convert these
metabolic signals intoCBFchanges (Vlassenkoetal., 2006). Thus,
astrocytes may contribute to the high temporal and spatial corre-
lation of blood flow increase and glucose consumption observed
in functional brain imaging (Raichle and Mintun, 2006).
EXPERIMENTAL PROCEDURES
Animal Surgery and Stimulation
Adult OMP-spH or GFAP-GFPmice (Jackson Laboratories) were anesthetized
with urethane (1.5 mg/kg i.p.; Sigma) and were freely breathing room air. Body
temperature was maintained at 37C by a heating blanket (Harvard Appara-
tus). An aluminum plate was glued to the skull, and the bulb was exposed using
a dental drill. The dura was removed when drugs were applied topically. The
surface was kept moist with artificial cerebrospinal fluid (aCSF; 135 mM
NaCl, 5.4 mM KCl, 5 mMHEPES, and 1.8 mMCaCl2 [pH 7.4]). Before imaging,
1.5% agarose in aCSF was placed on the bulb and the window was closed
with a coverslip. Respiration was monitored with a piezo transducer and re-
mained constant throughout experiments. Oxygen saturation and heart rate
were monitored with a pulse oximeter (Nonin). In a series of parallel experi-
ments, the femoral artery was cannulated for blood pressure and blood gas908 Neuron 58, 897–910, June 26, 2008 ª2008 Elsevier Inc.determination (Radiometer; mean arterial pressure, 75 ± 6 mmHg; pO2, 81 ± 3;
pCO2, 35 ± 4 [pH, 7.33 ± 0.2]; n = 18). All experiments were approved by the
Standing Committee on the Use of Animals in Research of Harvard University.
Odorants (Sigma; Table S1) were delivered by a custom-built automated
odor delivery system controlled by custom-written software in Labview
(National Instruments). Interstimulus interval was >2 min.
Pharmacology
Topically applied drugs were dissolved in aCSF. MPEP (Tocris), DHK (Sigma),
APV (Sigma), CNQX (Tocris), baclofen (Tocris), SC-560 (Cayman), TBOA (Toc-
ris), and MCPG (Tocris) were dissolved in aCSF and injected locally into the
bulb using a glass pipette (tip diameter 3 mm) connected to a Picospritzer II
(10 p.s.i., 200 ms; Parker). Injections were monitored by coloading pipettes
with Texas red (1%; Figure S1). Concentrations were based on initial experi-
ments and reports (Westerink and De Vries, 2001; Gurden et al., 2006) that ef-
fective concentrations are 100- to 1000-fold reduced in the brain in vivo. The
concentrations of baclofen (McGann et al., 2005), APV (Wang et al., 2006),
CNQX (Takano et al., 2006), MCPG (Gurden et al., 2006), MPEP (Takano
et al., 2006), TBOA (Gurden et al., 2006), DHK (Dawson et al., 2000), and
SC-560 (Takano et al., 2006) correspond to those used in other in vivo studies.
Acetazolamide (Sigma) was applied systemically by tail vein injection.
Multiphoton Imaging
A custom-built two-photon microscope (Tsai et al., 2002) was used for in vivo
imaging. Plasma was labeled with Texas red dextran 70 kDa (5% in saline,
Invitrogen) or FITC dextran 100 kDa (Sigma). Fluorophores were excited and
imaged with a water immersion objective (203, 0.95 NA, Olympus) at 910 nm
using a Ti:Sapphire laser (8W, Coherent) with a 150 fs pulse width and 76MHz
repetition rate. Image acquisition and scanning were controlled by custom-
written software in Labview. Velocity and flux were determined by serial line
scans. Cross-sectional area was determined semiautomatically from binarized
image sequences using ImageJ (W. Rasband, National Institutes of Health).
Radius, calculated from cross-sectional area, was used to determine relative
changes in flow according to Poiseuille’s law (assuming constant pressure
drop, viscosity, and length during the imaging period). Baseline CBF parame-
ters in glomerular capillaries were obtained during the presentation of pure air
preceding a stimulus. Vascular reactivity was tested after injection of acetazol-
amide at intervals of 1 min for 20 min.
Wide-Field Imaging and Electrophysiology
Glomeruli were visualized using a custom-built imaging device (Albeanu et al.,
2008) using blue light (LED arrays, 470 nm, Philips Lumileds). The emitted light
was filtered with a 505 nm long-pass filter and recorded with a CCD camera
(CCD-1300, Vossku¨hler) at 4 Hz. For nerve layer recordings, glass electrodes
were pulled (P-97, Sutter, 1–2 mm tip) and filled with saline and Alexa 488
Neuron
Astrocytic Control of Olfactory Blood Flow(20 mM; Invitrogen). Electrodes were placed perpendicularly to the surface in
glomeruli using a micromanipulator (MP-225, Sutter). Signals were filtered at
0.1–10 kHz and recorded with Spike2 software (CED).
Calcium Dye Loading
X-Rhod-1 AM (Invitrogen) was solubilized in 20% Pluronic F-127 in DMSO
(Invitrogen) to 10mM, then sonicated and diluted in aCSF to 1mM. Themixture
was filtered, loaded into glass pipettes (3–6 mm tip), and injected using a Picos-
pritzer II (5–7 p.s.i., 30–60 s). For M/T cell labeling, X-Rhod-1 AM (2 mM) was
injected into theM/T cell layer at a lower pressure (2–3 p.s.i., 10min). This tech-
nique resulted in sparse labeling of M/T cell bodies and apical dendrites. For
perivascular astrocyte labeling, X-Rhod-1 AM (2 mM) was applied topically
after dura removal for 70 min.
Immunohistochemistry
Mice were anesthetized with ketamine (100 mg/kg i.p.; Webster) and xylazine
(10 mg/kg i.p.; Webster) and transcardially perfused with 4% paraformalde-
hyde. Sagittal sections from the olfactory bulb (60 mm) were taken with a vibra-
tome (Leica). They were permeabilized and blocked in 0.3% Triton X-100
(Fisher) and 10% horse serum for 1 hr, and incubated with primary antibodies
against GFAP (rabbit, 1:1000; Z0334, Dako), laminin B2/g1 (rat, 1:1000; RT-
795, Lab Vision), aquaporin-4 (rabbit, 1:200; AB3068, Chemicon), COX1
(mouse, 1:200; 160110, Cayman), COX2 (rabbit, 1:200; 160116, Cayman), or
NeuN (mouse, 1:200; MAB377, Millipore) in 5% horse serum and 0.05% Triton
X-100 at 4C for 24 hr. Secondary antibodies (Alexa 568-conjugated goat anti-
rabbit or goat anti-mouse, Alexa 647-conjugated goat anti-rat, 1:250; Invitro-
gen) were applied for 3 hr at room temperature. Cell nuclei were stained with
Hoechst 33258 (1:1000, Invitrogen). Sections were imaged with a confocal
microscope (Zeiss).
Data Analysis
Raw spH fluorescence traces were corrected for photobleaching, assuming
a single exponential decay. Raw Ca2+ indicator traces were corrected by sub-
tracting trials with pure air presentation. Erythrocyte velocity was determined
from the slope of the bands (Figure 2F) by an automated routine in Matlab
(Mathworks) provided to us by Dr. C.B. Schaffer (Cornell University) (Schaffer
et al., 2006). Flux was calculated by binarizing and counting line scan bands
with ImageJ. Maximal changes were calculated as the ratio of maximal value
to mean value obtained during air presentation. Data are expressed as mean ±
SEM. p < 0.05 was accepted as statistically significant.
SUPPLEMENTAL DATA
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/58/6/897/DC1/.
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